Luke Evnin

Luke Evnin is an accomplished professional with extensive experience in biotechnology and venture capital. Since July 2020, Luke has served as the Proprietor of Annulus Cellars. Luke has held leadership roles at Werewolf Therapeutics since 2016, where responsibilities include Founder, Start-up CEO, and Chairperson. As Managing Director at MPM Capital since November 1997, Luke has contributed to strategic investment initiatives. Additionally, Luke has been the Chairperson of the Scleroderma Research Foundation since 1999. Prior to these roles, Luke was a General Partner at Accel Partners from 1990 to 1997. Luke's educational background includes a PhD in Biochemistry from the University of California, San Francisco, and a Bachelor's Degree in Molecular Biology from Princeton University.